Simplex Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,801
| Closed | -$104K | – | 10508 |
|
|
2023
Q1 | $62K | Sell |
14,801
-7,688
| -34% | -$39.9K | ﹤0.01% | 5694 |
|
|
2022
Q4 | $135K | Sell |
22,489
-17,882
| -44% | -$97.6K | ﹤0.01% | 4720 |
|
|
2022
Q3 | $234K | Sell |
40,371
-55,428
| -58% | -$345K | ﹤0.01% | 4409 |
|
|
2022
Q2 | $571K | Sell |
95,799
-62,682
| -40% | -$321K | ﹤0.01% | 3281 |
|
|
2022
Q1 | $740K | Buy |
158,481
+76,355
| +93% | +$228K | ﹤0.01% | 3316 |
|
|
2021
Q4 | $203K | Buy |
+82,126
| New | +$201K | ﹤0.01% | 5174 |
|
|
2021
Q2 | – | Sell |
-6,688
| Closed | -$16K | – | 11150 |
|
|
2021
Q1 | $19K | Buy |
6,688
+5,380
| +411% | +$17.6K | ﹤0.01% | 7517 |
|
|
2020
Q4 | $0 | Buy |
1,308
+1,213
| +1,277% | +$4.04K | ﹤0.01% | 9541 |
|
|
2020
Q3 | $0 | Buy |
+95
| New | +$121 | ﹤0.01% | 9015 |
|
|
2019
Q2 | – | Sell |
-6,997
| Closed | -$6.46K | – | 8351 |
|
|
2019
Q1 | $6K | Buy |
+6,997
| New | +$7.37K | ﹤0.01% | 6450 |
|
|
2018
Q4 | – | Sell |
-48,819
| Closed | -$80.2K | – | 8501 |
|
|
2018
Q3 | $105K | Buy |
48,819
+47,570
| +3,809% | +$118K | ﹤0.01% | 4392 |
|
|
2018
Q2 | $6K | Buy |
+1,249
| New | +$5.47K | ﹤0.01% | 6671 |
|
|
2017
Q3 | – | Sell |
-745
| Closed | -$2K | – | 7282 |
|
|
2017
Q2 | $2K | Buy |
+745
| New | +$2.9K | ﹤0.01% | 5468 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$459 | – | 7056 |
|
|
2016
Q1 | $0 | Sell |
100
-2,587
| -96% | -$20.7K | ﹤0.01% | 6976 |
|
|
2015
Q4 | $33K | Buy |
2,687
+2,675
| +22,292% | +$35.7K | ﹤0.01% | 2280 |
|
|
2015
Q3 | $0 | Sell |
12
-1,290
| -99% | -$22.3K | ﹤0.01% | 6918 |
|
|
2015
Q2 | $25K | Sell |
1,302
-1,475
| -53% | -$28.5K | ﹤0.01% | 2289 |
|
|
2015
Q1 | $50K | Buy |
+2,777
| New | +$62.5K | 0.01% | 1579 |
|
Simplex Trading's CTIC Position: Q2 2023 in Review
Simplex Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 14,801 shares — an estimated $104K sold.
Simplex Trading first reported a position in CTIC in Q1 2015 and held it in 18 quarters. The position peaked at $740K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Simplex Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 14,801 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $104K.
- Simplex Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 18 quarters.
- Simplex Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $740K in Q1 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.